Zero to Hero? Scope 3 Emissions – A Strategic Imperative for Pharma Companies Verena Ahnert Read more
Special Report Contract/Pharma Services Advancing Innovation and Global Reach: The Next Chapter in China’s Clinical Trial… November 12, 2025
Executive Insights Life Sciences & Pharma Unleashing Growth: How Innovation Is Reshaping Animal Health September 12, 2025
Executive Insights Life Sciences & Pharma Animal Pharma: Unlocking Value Through Growth and Investment May 21, 2025
Case Study Organization & Performance Procurement Excellence as Competitive Advantage: Lowering Costs to Elevate Products May 6, 2025
Executive Insights Life Sciences & Pharma Radiotherapeutics on the Rise: Addressing Supply Chain Complexity April 7, 2025
Video / Webinar Healthcare Services Australia's Clinical Trials: Innovation and Growth February 24, 2025
